EVOLUTION OF GROUP A STREPTOCOCCI
EVOLUTION OF GROUP A STREPTOCOCCI
批准号:
6787036
负责人:
Debra E BESSEN
金额:
$28.27万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-02-01 至 2006-01-31
关键词:
Streptococcus pyogenes alleles bacterial antigens biochemical evolution gene expression genetic mapping genetic recombination genetic strain human tissue immunity laboratory rabbit microorganism population study nucleic acid hybridization population genetics serotyping southern blotting surface antigens
中文摘要
描述(改编自申请者摘要):群体遗传
A组化脓性链球菌的结构将进行多项研究
具有全球代表性的600个样本的基因座序列分型
菌株使用7个不同的基因座。来自另外200个污渍的数据将
在这个项目开始之前,已经用其他资金获得了。
将选择276个细菌进行MLST,以代表EMM的多样性
序列分型(Emmst),其中146种是目前已知的类型,来自AS
尽可能多样化的来源和时间段。额外的Emmst将是
已执行。数据将通过聚类分析进行差异分析
等位基因、关联指数和系统发育树,以确定
重要的是重组的作用是。猪的SPEA和SPEC等位基因
个别菌株也将接受测试。中国人口的分布
M-蛋白和MLST检测的看家基因将与
确定它们之间的关联程度。这些分析将检验这一假设
M蛋白导致了更多分离的EMM模式A-C菌株
亚群高于EMM型D株。
第二种假设是,在E型EMM菌株中,两组多态
抗原(emm加sof)可激发免疫反应,免疫已选定
在这些抗原中不重叠的菌株(古普塔的双表位模型)。至
验证这一假设,多克隆抗血清将针对
重叠的重组sOF多肽及其类型特异性位点
通过确定哪个重叠区域在不同的
重组多肽。该类型特定区域将从所有
模式E分离。将使用双向列联表来确定
Emmst和sof等位基因的组合是否如
假设或随机。基于EMM的人免疫球蛋白亚类,IgA,
纤溶酶原和纤维蛋白原将通过Southern杂交和
数据的分析方法与上面类似。届时将再增加325个菌株
根据上述分析的结果选择进行短期分析
特定情况下的流行病学。将执行相同的分析,如
第一组菌株。
最后,对emm和sof产品的抗血清进行竞争性分析。
抑制、调理和抑制配体与
细菌。不同M蛋白之间的交叉反应性将是相关的
系统发育分析和免疫选择模型。
在免疫后将获得更多的抗血清并进行检测
Emmst和sof基因产物的类型特异性表位。这些血清将是
测试以确定应变结构是否由
Emm和sof基因产物的免疫原性。
英文摘要
DESCRIPTION (Adapted from the Applicant's Abstract): The population genetic
structure of group A Streptococcus pyogenes will be investigated by multi
locus sequence typing (MLST) of a globally representative sample of 600
strains using 7 distinct gene loci. Data from an additional 200 stains will
have been obtained with other funding prior to the beginning of this project.
276 bacteria will be selected for MLST to represent the diversity of emm
sequence typing (emmst), of which 146 types are currently known, and from as
diverse sources and time periods as possible. Additional emmst will be
performed. The data will be analyzed by cluster analysis of differences in
alleles, indices of association, and phylogenetic trees to determine how
important the role of recombination is. The speA and speC alleles of the
individual strains will also be tested. The population distributions of the
M-protein and the housekeeping genes tested by MLST will be compared to
determine how well they correlate. These analyses will test the hypothesis
that the M protein has led to more discrete strains in the emm pattern A-C
subpopulation than in the emm pattern D strains.
A second hypothesis is that in emm pattern E strains, two sets of polymorphic
antigens (emm plus sof) elicit immune responses and immunity has selected
strains that do not overlap in these antigens (Gupta's two epitope model). To
test this hypothesis, polyclonal antisera will be generated against
overlapping recombinant sof polypeptides and the type-specific sites for
binding mapped by determining which overlapping region reacts in the different
recombinant peptides. That type-specific region will be sequenced from all
pattern E isolates. Two-way contingency tables will be used to determine
whether the combinations of emmst and sof alleles are as predicted by the
hypothesis or random. Emm-based binding sites for human IgG subclasses, IgA,
plasminogen and fibrinogen will be screened by Southern hybridization and the
data will be analyzed similarly to above. An additional 325 strains will then
be chosen based on the results from the above analyses to analyze short term
epidemiology from defined situations. The same analyses will be performed as
with the first set of strains.
Finally, the antisera to emm and sof products will be analyzed by competitive
inhibition, opsonization and for inhibition of binding of ligands to the
bacteria. Cross 0- reactivity between different M proteins will be correlated
with the phylogenetic analyses and models for selection by immunity.
Additional antisera will be obtained and tested after immunization with
type-specific epitopes of emmst and sof gene products. These sera will be
tested to determine whether strain structure is determined by the
immunogenicity of the emm and sof gene products.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protective antibody in streptococcal infection models
-
批准号:10576491
-
项目类别:
-
资助金额:$59.39万
-
财政年份:2022
-
负责人:Debra E BESSEN
-
依托单位:
Macrolide resistance transfer in Streptococcus pyogenes
-
批准号:10474268
-
项目类别:
-
资助金额:$20.31万
-
财政年份:2021
-
负责人:Debra E BESSEN
-
依托单位:
Pilin Genotyping for Group A Streptococci
-
批准号:10056809
-
项目类别:
-
资助金额:$8.33万
-
财政年份:2020
-
负责人:Debra E BESSEN
-
依托单位:
Pilin Genotyping for Group A Streptococci
-
批准号:10171765
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2020
-
负责人:Debra E BESSEN
-
依托单位:
Population analysis of group A streptococcal phenotypes
-
批准号:9035797
-
项目类别:
-
资助金额:$25.69万
-
财政年份:2015
-
负责人:Debra E BESSEN
-
依托单位:
Population analysis of group A streptococcal phenotypes
-
批准号:9196327
-
项目类别:
-
资助金额:$20.3万
-
财政年份:2015
-
负责人:Debra E BESSEN
-
依托单位:
Tissue-Specific Infection by Group A Streptococci
-
批准号:7872639
-
项目类别:
-
资助金额:$39.48万
-
财政年份:2009
-
负责人:Debra E BESSEN
-
依托单位:
Population genomics of Streptococcus pyogenes
-
批准号:6955359
-
项目类别:
-
资助金额:$24.28万
-
财政年份:2005
-
负责人:Debra E BESSEN
-
依托单位:
Population genomics of Streptococcus pyogenes
-
批准号:7369749
-
项目类别:
-
资助金额:$34.71万
-
财政年份:2005
-
负责人:Debra E BESSEN
-
依托单位:
Population genomics of Streptococcus pyogenes
-
批准号:7194215
-
项目类别:
-
资助金额:$47.01万
-
财政年份:2005
-
负责人:Debra E BESSEN
-
依托单位:
Population genomics of Streptococcus pyogenes
-
批准号:7570089
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2005
-
负责人:Debra E BESSEN
-
依托单位:
Population genomics of Streptococcus pyogenes
-
批准号:7074614
-
项目类别:
-
资助金额:$42.16万
-
财政年份:2005
-
负责人:Debra E BESSEN
-
依托单位:
Molecular Evolution of Resistance in Strep. pyogenes
-
批准号:6893694
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2004
-
负责人:Debra E BESSEN
-
依托单位:
Molecular Evolution of Resistance in Strep. pyogenes
-
批准号:6816037
-
项目类别:
-
资助金额:$19.49万
-
财政年份:2004
-
负责人:Debra E BESSEN
-
依托单位:
Tissue-Specific Infection by Group A Streptococci
-
批准号:6760024
-
项目类别:
-
资助金额:$29.51万
-
财政年份:2003
-
负责人:Debra E BESSEN
-
依托单位:
Tissue-Specific Infection by Group A Streptococci
-
批准号:7005423
-
项目类别:
-
资助金额:$28.48万
-
财政年份:2003
-
负责人:Debra E BESSEN
-
依托单位:
Tissue-Specific Infection by Group A Streptococci
-
批准号:7156973
-
项目类别:
-
资助金额:$27.66万
-
财政年份:2003
-
负责人:Debra E BESSEN
-
依托单位:
Tissue-Specific Infection by Group A Streptococci
-
批准号:6846636
-
项目类别:
-
资助金额:$29.17万
-
财政年份:2003
-
负责人:Debra E BESSEN
-
依托单位:
Tissue-Specific Infection by Group A Streptococci
-
批准号:6786466
-
项目类别:
-
资助金额:$15.55万
-
财政年份:2003
-
负责人:Debra E BESSEN
-
依托单位:
Tissue-Specific Infection by Group A Streptococci
-
批准号:7623275
-
项目类别:
-
资助金额:$41.35万
-
财政年份:2002
-
负责人:Debra E BESSEN
-
依托单位:
海外基金